RxDoctor Payments Data

Jian Zhang, DPM

Foot Surgery · Bronx, NYNPI 1306882444

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Kerecis Limited at 26.1% of the total.

$4,099in general payments, 2019–2025

Across 78 payments — averaging $52.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$1K
  • Smith+Nephew$789
  • Paratek Pharmaceuticals, Inc.$407
  • Integra Lifesciences Corporation$263
  • Organogenesis Inc.$248
  • Royal Biologics, Inc.$185
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,099 in reported general payments places this provider in the 85th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$98,998
Medicare patients
159
Services billed
1,022

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate107$2,279
Pregabalin24$1,053
Doxycycline Monohydrate22$735
CiclopiroxCiclopirox Olamine11$466
Ketoconazole13$392
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav53$375
Triamcinolone Acetonide47$209
Meloxicam53$162
Gabapentin21$127
Terbinafine Hcl22$95
Mupirocin20$93
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$90
Methylprednisolone19$75
Ciprofloxacin Hcl15$74

Paid to pharmacies, not to this prescriber.

Other foot surgery in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →